Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Lipidol. 2003 Apr;14(2):137-43.

Liver X receptors: new players in atherogenesis?

Author information

  • 1UMR 545 INSERM, Department of Atherosclerosis, Lille Pasteur Institute, Lille, France, and Faculty of Pharmacy, University of Lille II, Lille, France.

Abstract

PURPOSE OF REVIEW:

The liver X receptors (alpha and beta) are oxysterol-activated nuclear receptors. A large number of liver X receptor target genes with functions in lipid homeostasis have been identified. Increasing evidence indicates that these receptors play a beneficial role in avoiding cholesterol overload by intervening at several steps of cholesterol metabolism. In this review, we describe the most recent developments concerning their functions in cholesterol and lipid metabolism and their impact in atherogenesis.

RECENT FINDINGS:

Although potentially undesirable effects of liver X receptor activation on triglyceride metabolism have been observed, recent in-vivo studies confirm that the overall trend is a reduction of atherogenesis.

SUMMARY:

Consequently, liver X receptors are becoming therapeutic targets of great interest for the treatment of atherosclerosis, especially if their action on triglyceride and cholesterol metabolism can be dissociated and isoform-specific ligands identified.

PMID:
12642781
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk